Article Information
History
- September 3, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Xiaoyu Song, DrPH1,2,*,
- Jiayi Ji, MS1,2,
- Boris Reva, PhD3,
- Himanshu Joshi, MBBS PhD1,
- Anna Pamela Calinawan, MS3,
- Madhu Mazumdar, PhD1,2,
- Emanuela Taioli, MD PhD2,4,
- Pei Wang, PhD3 and
- Rajwanth Veluswamy, MD MSCR2,4,5,*
- 1Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY
- 2Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
- 3Department of Genetics and Genomic Sciences and Icahn Institute for Data Science and Genomic Technology, Icahn School of Medicine at Mount Sinai, New York, NY
- 4Institute for Translational Epidemiology, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY
- 5Department of Medicine, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
- ↵* Co-corresponding authors: Rajwanth R. Veluswamy, MD MSCR, Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1079, New York, New York 10029, rajwanth.veluswamy{at}mssm.edu, Xiaoyu Song, DrPH, Department of Population Health Science and Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1077, New York, New York 10029, xiaoyu.song{at}mountsinai.org
Posted September 03, 2020.
Post-Anticoagulant D-dimer as a Highly Prognostic Biomarker of COVID-19 Mortality
